Delivering on the Potential of Biosimilar Medicines

29 Mar 2016

The purpose of this report is to describe the potential role for biosimilars and their contribution to healthcare systems; the risks for stakeholders to realize that full potential value; and the requirements for competitive functioning markets in order to capture the full value. It draws on analysis of trends across EU nations over the past decade and observations of the differing practices undertaken by stakeholder groups.

To listen to the media briefing, click here.

To view the media briefing presentation, click here.